Press Releases

Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This life-changing therapy is available for patients whose mitral valves are not functioning properly due to severe mitral annular calcification (MAC), a buildup of calcium within the ring-like structure (known as an annulus) that supports the mitral valve. The complex nature o

Perimeter Medical Imaging AI, Inc. a commercial-stage medical technology company, is pleased to announce that it has entered into a Development Support Agreement ("DSA") with Salt Lake City-based Intermountain Health, the largest nonprofit health system in the Intermountain West. This agreement creates the framework for the two organizations to partner on a number of future studies evaluating the potential value of using Perimeter's OCT and collecting additional data to support

AI Medical Technology (AIM) has received CE mark approval for Dermalyser, its diagnostic decision support tool for melanoma detection. Designed for use on smartphones attached to a dermatoscope, the AI-powered tool has demonstrated superior performance compared to experienced dermatologists and is now cleared for use across Europe. Dermalyser is a stand-alone Medical Device Software (MDSW). Its clinical performance was validated through AI-DSMM, a real-world trial conducted at 36 pr

Esaote, a leading company in the field of medical diagnostic imaging, has presented the world premiere of the new MyLab™Heron ultrasound system at the Congress organized in Rimini from May 23 to 25 May by SCIVAC, the largest Veterinary Scientific Society in Italy, the objective of which is the scientific and professional education of veterinarians. MyLab™Heron is the latest result of Esaote's research activity in high-performance portable ultrasound systems, in which

Comac Medical Group ("Group"), based in the UK and backed by EdgeCap Partners, announced today the acquisition of ILIFE Consulting ("ILIFE"), a specialized Contract Research Organization (CRO) headquartered in Paris, France, renowned for its expertise in oncology, rare diseases, and complex biotech clinical trials. The transaction represents a significant milestone for the Group on its journey to becoming the leading pan-European full-service CRO partner for smal

Lunit, a leading provider of AI for cancer diagnostics and therapeutics, today announced major milestones in the United States, one year after its acquisition of Volpara Health Technologies. Since acquiring Volpara, Lunit has significantly expanded its presence across North America. By June 2025, Lunit's AI solutions for digital breast tomosynthesis (Lunit INSIGHT DBT) and mammography analysis (Lunit INSIGHT MMG) will be deployed at over 200 imaging centers and hospitals across

Altera Digital Health is proud to announce the successful activation of its integrated operating theater system at Latrobe Regional Health (LRH), one of the hospital members of Gippsland Health Alliance (GHA). GHA has been leveraging Sunrise™ as its enterprise-wide electronic health record (EHR) platform, utilizing Microsoft Azure to enhance interoperability, security and scalability across its network. As part of its ongoing digital transformation, GHA has now implemented an

Massachusetts based Trax Surgical, LLC, an orthopedic product development and distribution company principally serving the needs of the orthopedic extremities market, announced today that they received FDA 510(k) clearance to market the LINKT™ Compression Staple System. The staple system offers a range of nitinol staples for fracture repair, joint fusion, and osteotomy procedures. Compression bone staples have a key intraoperative advantage in that they are technically easier

MedX Health Corp. the global leader in teledermatology solutions, is pleased to announce the signing of a commercial contract with Health Partners Group Ltd (“HPG” or “Health Partners Group”), the United Kingdom’s largest occupational health services provider. This agreement follows the successful completion of a pilot project across two of HPG’s clients, utilizing MedX’s DermSecure® skin cancer screening platform. Following the pilot&rs

Autonomix Medical, Inc, a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,257,071 (‘071 patent) titled Controlled sympathectomy and micro-ablation systems and methods. The newly issued ‘071 patent relates to, but is not necessarily limited to, advanced catheter-based systems that combine nerve mapping and radiofrequency (RF) ablation technologies,